Physician profile
David M Shafer
NPI 1922078468
$1,489,979.70
in general payments reported to CMS, 2019-2025
13 companies · $273K in 2025
The $273K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115K · 2020: $94K · 2021: $165K · 2022: $300K · 2023: $354K · 2024: $189K · 2025: $273K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $510K · Consulting Fee: $260K · Travel and Lodging: $38K · Food and Beverage: $8,118 · Education: $67.60 · Entertainment: $59.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $510,197.40 |
| Consulting Fee | $259,725.00 |
| Travel and Lodging | $37,870.72 |
| Food and Beverage | $8,117.80 |
| Education | $67.60 |
| Entertainment | $59.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $808,576.78 | 2022-2025 | Botox, Kybella |
| Allergan, INC. | $664,910.85 | 2019-2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $8,250.00 | 2025 | Clear+Brilliant |
| Sientra, INC. | $5,927.42 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,003.65 | 2023-2025 | |
| Merz North America, INC. | $804.52 | 2019-2023 | Xeomin |
| Motiva USA, LLC | $166.64 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $159.79 | 2021-2022 | |
| Revance Therapeutics, INC. | $46.86 | 2025 | Daxxify |
| Davol INC. | $46.06 | 2022 | |
| Galderma Laboratories, L.P. | $44.25 | 2022-2023 | |
| Kci USA, INC. | $22.55 | 2020 | |
| Leo Pharma INC. | $20.33 | 2025 | Anzupgo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shafer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.